Product Description: Envudeucitinibum (Envudeucitinib) is a Janus kinase inhibitor, with anti-inflammatory effect[1].
Applications: COVID-19-immunoregulation
Formula: C22H18D6N6O3
References: [1]Envudeucitinibum (Envudeucitinib). WHO Drug Information, Vol. 37, No. 4, 2023.
CAS Number: 2417135-66-9
Molecular Weight: 426.50
Research Area: Inflammation/Immunology
Target: JAK